✨ Unlock Data Exports And Disclosure Access. Start Your 30-Day Free Trial Today →

China Resources Double-Crane Pharmaceutical Co Ltd

Common Name
CR Double-Crane
Country
China (Mainland)
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
13,414
Ticker
600062
Exchange
SHANGHAI STOCK EXCHANGE
Description
China Resources Double Crane Pharmaceutical Co., Ltd. is a prominent player in the pharmaceutical industry, primarily engaged in the research, development, manufacturing, and distribution of a variety...

CR Double-Crane's GHG Emissions Data Preview

In 2024, CR Double-Crane completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources) and Scope 2 (indirect emissions from purchased energy).

However, CR Double-Crane has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.

Metric (tCO2e)202420232022
2021 - 2017
Total Scope 1
0000000
Copy/Paste is a PRO feature.
a
Copy/Paste is a PRO feature.
a
0000000
Total Scope 2
Unspecified Calculation Method
Copy/Paste is a PRO feature.
a
0000000
Copy/Paste is a PRO feature.
a
0000000
Total Scope 3
Copy/Paste is a PRO feature.
Copy/Paste is a PRO feature.
b
0000000
0000000
Total Scope 1 Revenue Intensity (tCO2e/$M)
0000000
Copy/Paste is a PRO feature.
a
Copy/Paste is a PRO feature.
a
0000000
Limited Data Preview
You are viewing a limited preview of CR Double-Crane’s GHG emissions dataset. The full dataset, available for download, includes Scope 1, 2, and 3 emissions with detailed category-level breakdowns, historical coverage back to 2021, and revenue-based intensity metrics for each scope.
Access Datasets, Disclosures, and Sources
pro
Remove manual data sourcing from your workflow. Subscribe to Tracenable Pro to get credits for accessing and exporting datasets and disclosures across 8,500+ companies with 10+ years of historical coverage.
Download granular datasets (CSV/XLS)
Access underlying corporate disclosures (PDF)
Trace all values back to their original sources
Formats Included
Excel
CSV
Json
All data fully traceable to original sources
Used by 1,000+ teams in finance, climate, and research
Access this data via API
$curl "https://tracenable.com/api/v1/ghg-emissions/absolute?ticker=600062&reporting_period=2024"

Verified Sources Behind CR Double-Crane’s Greenhouse Gas (GHG) Emissions Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore CR Double-Crane’s data sources below and access millions more through our Disclosure Search.

a. CR Double-Crane's Sustainability Report 2024
b. CR Double-Crane's Sustainability Report 2023

Insights into CR Double-Crane's Operational Emissions

In 2024, the total operational greenhouse gas (GHG) emissions of CR Double-Crane amounted to 297,839.7 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).a

Compared to 2023, the total operational greenhouse gas (GHG) emissions of CR Double-Crane increased by 22.51%, suggesting that the company faced challenges in reducing its emissions from its core operations.a

CR Double-Crane's Scope 1 Emissions Over Time

2021202220232024015 k30 k45 k60 ktCO2e-6%+8%+13%
  • Total Scope 1
  • Year-over-Year Change

What are CR Double-Crane's Scope 1 emissions?

In 2024, the total Scope 1 emissions of CR Double-Crane were 58,154.59 metric tons of CO₂ equivalent (tCO₂e).a

Has CR Double-Crane reduced its Scope 1 emissions over time?

Since 2021, CR Double-Crane's Scope 1 emissions have increased by 14.81%, reflecting a rising long-term trend in Scope 1 emissions over time.ab

Compared to the previous year (2023), CR Double-Crane's Scope 1 emissions increased by 12.68%, suggesting that the company faced challenges in reducing emissions from its directly owned or controlled operations.a

What are CR Double-Crane's Scope 2 emissions?

In 2024, CR Double-Crane reported Scope 2 greenhouse gas (GHG) emissions of 239,685.11 tCO₂e without specifying the calculation method.a

Has CR Double-Crane reduced its Scope 2 emissions over time?

Since 2021, CR Double-Crane's Scope 2 greenhouse gas (GHG) emissions (Unspecified Calculation Method) have increased by 35.31%, reflecting a rising long-term trend in Scope 2 emissions over time.ab

Compared to the previous year (2023), CR Double-Crane's Scope 2 emissions (Unspecified Calculation Method) rose by 25.15% in 2024, suggesting that the company faced challenges in reducing emissions from purchased electricity and energya

What methodology does CR Double-Crane use for Scope 2 reporting?

In 2024, CR Double-Crane reported its Scope 2 emissions using an unspecified methodology.a

CR Double-Crane's Scope 2 Emissions Over Time

2021202220232024060 k120 k180 k240 ktCO2e
  • Total Scope 2 (Unspecified Calculation Method)

Insights into CR Double-Crane’s GHG Emissions Intensity Compared to Industry Peers

In 2024, CR Double-Crane reported Scope 1 greenhouse gas (GHG) emissions of 58,154.59 tCO₂e and total revenues of USD 1,536 millions. This translates into an emissions intensity of 37.86 tCO₂e per millions USD.a

CR Double-Crane's Scope 1 Emissions Intensity Compared to Peers

102002,00050,000500,000Scope 1 Emissions (tCO2e)5502002,00010,000Revenues (Millions of USD)CHPADSDCCCanSino BiologicsYear: 2023Scope 1: 3,541 tCO2eRevenue: $M 49Scope 1 Intensity: 72.91 tCO2e/$MSimcere Pharmaceutical GroupYear: 2023Scope 1: 4,997 tCO2eRevenue: $M 1,017Scope 1 Intensity: 4.91 tCO2e/$MWalvax BiotechnologyYear: 2024Scope 1: 7,643 tCO2eRevenue: $M 387Scope 1 Intensity: 19.77 tCO2e/$MHumanwell Healthcare GroupYear: 2024Scope 1: 19,500 tCO2eRevenue: $M 3,485Scope 1 Intensity: 5.60 tCO2e/$MLuye Pharma GroupYear: 2023Scope 1: 10,755 tCO2eRevenue: $M 945Scope 1 Intensity: 11.38 tCO2e/$MLivzon Pharmaceutical GroupYear: 2024Scope 1: 194,441 tCO2eRevenue: $M 1,619Scope 1 Intensity: 120.13 tCO2e/$MCCChangchun High-TechYear: 2023Scope 1: 61,590 tCO2eRevenue: $M 2,050Scope 1 Intensity: 30.05 tCO2e/$MHansoh Pharmaceutical GroupYear: 2024Scope 1: 13,163 tCO2eRevenue: $M 1,830Scope 1 Intensity: 7.19 tCO2e/$MHHHuadong MedicineYear: 2024Scope 1: 15,595 tCO2eRevenue: $M 5,742Scope 1 Intensity: 2.72 tCO2e/$MJoincareYear: 2024Scope 1: 197,854 tCO2eRevenue: $M 2,140Scope 1 Intensity: 92.45 tCO2e/$MPPPorton Pharma SolutionsYear: 2024Scope 1: 18,865 tCO2eRevenue: $M 413Scope 1 Intensity: 45.71 tCO2e/$MBioKangtaiYear: 2023Scope 1: 15,952 tCO2eRevenue: $M 489Scope 1 Intensity: 32.60 tCO2e/$MZhejiang Jiuzhou PharmaceuticalYear: 2023Scope 1: 48,815 tCO2eRevenue: $M 777Scope 1 Intensity: 62.81 tCO2e/$MYunnan Baiyao GroupYear: 2024Scope 1: 15,079 tCO2eRevenue: $M 5,485Scope 1 Intensity: 2.75 tCO2e/$MConsun Pharmaceutical GroupYear: 2023Scope 1: 54,210 tCO2eRevenue: $M 398Scope 1 Intensity: 136.27 tCO2e/$MAAApeloa PharmaceuticalYear: 2024Scope 1: 10,400 tCO2eRevenue: $M 1,647Scope 1 Intensity: 6.31 tCO2e/$MDDDong-E-E-JiaoYear: 2023Scope 1: 15,659 tCO2eRevenue: $M 663Scope 1 Intensity: 23.60 tCO2e/$MFosun PharmaYear: 2024Scope 1: 184,016 tCO2eRevenue: $M 5,627Scope 1 Intensity: 32.70 tCO2e/$MJiangsu Hengrui PharmaceuticalsYear: 2024Scope 1: 8,517 tCO2eRevenue: $M 3,835Scope 1 Intensity: 2.22 tCO2e/$MSSSihuan PharmaceuticalYear: 2023Scope 1: 45,602 tCO2eRevenue: $M 286Scope 1 Intensity: 159.27 tCO2e/$MTasly Pharmaceutical GroupYear: 2024Scope 1: 37,370 tCO2eRevenue: $M 1,164Scope 1 Intensity: 32.09 tCO2e/$MHua MedicineYear: 2023Scope 1: 19 tCO2eRevenue: $M 12Scope 1 Intensity: 1.63 tCO2e/$MDDDa Ren TangYear: 2023Scope 1: 5,902 tCO2eRevenue: $M 1,157Scope 1 Intensity: 5.10 tCO2e/$MCCChina Resources SanjiuYear: 2024Scope 1: 55,312 tCO2eRevenue: $M 3,784Scope 1 Intensity: 14.62 tCO2e/$MBeijing Tong Ren TangYear: 2024Scope 1: 34,974 tCO2eRevenue: $M 2,548Scope 1 Intensity: 13.72 tCO2e/$MCCCR Double-CraneYear: 2024Scope 1: 58,155 tCO2eRevenue: $M 1,536Scope 1 Intensity: 37.86 tCO2e/$M

How does CR Double-Crane's GHG emissions intensity compare to its peers?

In 2024, CR Double-Crane reported a Scope 1 emissions intensity of 37.86 tCO₂e per millions USD. Compared to the peer group median of 19.77, this places the company above its industry benchmark, indicating it is less carbon-efficient than most competitors.a

Where does CR Double-Crane rank on GHG emissions intensity within its industry?

In 2024, CR Double-Crane ranked 19 out of 25 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD).a

CR Double-Crane is therefore positioned in the mid-range of its industry, neither a clear leader nor a laggard in carbon efficiency.a

Want Full Access to CR Double-Crane's GHG Emissions Dataset?
Start 30-Day Free Trial